Drug Type Small molecule drug |
Synonyms Barnidipine, Barnidipine hydrochloride (JAN), Cyress + [15] |
Target |
Mechanism Cav2.1 inhibitors(calcium voltage-gated channel subunit alpha1 A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (01 Jan 1992), |
Regulation- |
Molecular FormulaC27H30ClN3O6 |
InChIKeyXEMPUKIZUCIZEY-YSCHMLPRSA-N |
CAS Registry104757-53-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01104 | Barnidipine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Essential Hypertension | NL | 11 Jul 2000 | |
Hypertension, Renovascular | JP | 07 Sep 1994 | |
Parenchymal renal hypertension | JP | 03 Jul 1992 | |
Hypertension | JP | 01 Jan 1992 |
Not Applicable | - | gfndtffvpj(avihvykmih) = The two groups had a similar incidence of AEs leading to discontinuation (20.1 vs 17%), the most commonly reported being headache (38.5%), hypotension (30.8%), palpitations, flushing, and edema (7.7% each). No serious AE was reported in any group. phvsizwdca (dbjrztrnrx ) | - | 05 Jun 2024 | |||
MR-nifedipine 20mg/day | |||||||
Not Applicable | Diabetes Mellitus, Type 2 | Hypertension fasting plasma glucose | glycated hemoglobin | high-sensitivity C-reactive protein ... View more | 151 | (swafslrtjb) = npqsiqsgsz bvbxqhpjdz (ujtdciydpk ) View more | Positive | 01 Jun 2015 | ||
(swafslrtjb) = zlpicbnxix bvbxqhpjdz (ujtdciydpk ) View more | |||||||
Not Applicable | - | (ggwlqkhaml) = jnryihoodw zkmazbxwfi (cxoknpbtin, 10.8) | Positive | 11 Nov 2014 | |||
(ggwlqkhaml) = qajldgvecz zkmazbxwfi (cxoknpbtin, 13.8) |